Advanced structural brain aging in preclinical autosomal dominant Alzheimer disease
Tóm tắt
“Brain-predicted age” estimates biological age from complex, nonlinear features in neuroimaging scans. The brain age gap (BAG) between predicted and chronological age is elevated in sporadic Alzheimer disease (AD), but is underexplored in autosomal dominant AD (ADAD), in which AD progression is highly predictable with minimal confounding age-related co-pathology. We modeled BAG in 257 deeply-phenotyped ADAD mutation-carriers and 179 non-carriers from the Dominantly Inherited Alzheimer Network using minimally-processed structural MRI scans. We then tested whether BAG differed as a function of mutation and cognitive status, or estimated years until symptom onset, and whether it was associated with established markers of amyloid (PiB PET, CSF amyloid-β-42/40), phosphorylated tau (CSF and plasma pTau-181), neurodegeneration (CSF and plasma neurofilament-light-chain [NfL]), and cognition (global neuropsychological composite and CDR-sum of boxes). We compared BAG to other MRI measures, and examined heterogeneity in BAG as a function of ADAD mutation variants, APOE ε4 carrier status, sex, and education. Advanced brain aging was observed in mutation-carriers approximately 7 years before expected symptom onset, in line with other established structural indicators of atrophy. BAG was moderately associated with amyloid PET and strongly associated with pTau-181, NfL, and cognition in mutation-carriers. Mutation variants, sex, and years of education contributed to variability in BAG. We extend prior work using BAG from sporadic AD to ADAD, noting consistent results. BAG associates well with markers of pTau, neurodegeneration, and cognition, but to a lesser extent, amyloid, in ADAD. BAG may capture similar signal to established MRI measures. However, BAG offers unique benefits in simplicity of data processing and interpretation. Thus, results in this unique ADAD cohort with few age-related confounds suggest that brain aging attributable to AD neuropathology can be accurately quantified from minimally-processed MRI.
Tài liệu tham khảo
Raz N, Gunning FM, Head D, Dupuis JH, Mcquain J, Briggs SD, Loken WJ, Allen E, Acker JD. Selective aging of the Human Cerebral Cortex Observed in vivo: Differential vulnerability of the prefrontal Gray Matter. Cereb Cortex. 1997;7:268–82.
Resnick SM, Pham DL, Kraut MA, Zonderman AB, Davatzikos C. Longitudinal magnetic resonance imaging studies of older adults: a shrinking brain. J Neurosci. 2003;23:3295–301.
Bethlehem RAI, Seidlitz J, White SR, et al. Brain charts for the human lifespan. Nature. 2022. https://doi.org/10.1038/s41586-022-04554-y.
Franke K, Ziegler G, Klöppel S, Gaser C. Estimating the age of healthy subjects from T1-weighted MRI scans using kernel methods: exploring the influence of various parameters. NeuroImage. 2010;50:883–92.
Cole JH, Leech R, Sharp DJ. Prediction of brain age suggests accelerated atrophy after traumatic brain injury. Ann Neurol. 2015;77:571–81.
Cole JH, Franke K. Predicting Age using neuroimaging: innovative brain ageing biomarkers. Trends Neurosci. 2017;40:681–90.
Franke K, Gaser C. Ten years of brainage as a neuroimaging biomarker of brain aging: what insights have we gained? Front Neurol. 2019. https://doi.org/10.3389/fneur.2019.00789.
Jirsaraie RJ, Gorelik AJ, Gatavins MM, Engemann DA, Bogdan R, Barch DM. A systematic review of multimodal brain age studies: uncovering a divergence between model accuracy and utility. Patterns. 2023;4:100712.
Frisoni GB, Fox NC, Jack CR, Scheltens P, Thompson PM. The clinical use of structural MRI in Alzheimer Disease. Nat Rev Neurol. 2010;6:67–77.
Gaser C, Franke K, Klöppel S, Koutsouleris N, Sauer H. BrainAGE in mild cognitive impaired patients: Predicting the Conversion to Alzheimer’s Disease. PLoS ONE. 2013. https://doi.org/10.1371/journal.pone.0067346.
Sperling RA, Aisen PS, Beckett LA, et al. Toward defining the preclinical stages of Alzheimer’s Disease: recommendations from the National Institute on Aging and the Alzheimer’s Association workgroup. Alzheimer’s Dement. 2011;7:1–13.
Lee J, Burkett BJ, Min H, et al. Deep learning-based brain age prediction in normal aging and Dementia. Nat Aging. 2022. https://doi.org/10.1038/s43587-022-00219-7.
Karim HT, Aizenstein HJ, Mizuno A et al. (2022) Independent replication of advanced brain age in mild cognitive impairment and Dementia: detection of future cognitive dysfunction. Mol Psychiatry 1–9.
Wagen AZ, Coath W, Keshavan A, et al. Life course, genetic, and neuropathological associations with brain age in the 1946 British birth cohort: a population-based study. Lancet Heal Longev. 2022;3:e607–16.
Millar PR, Gordon BA, Luckett PH, et al. Multimodal brain age estimates relate to Alzheimer Disease biomarkers and cognition in early stages: a cross-sectional observational study. Elife. 2023;12:1–25.
Cumplido-Mayoral I, García- M, Falcon C, et al. Biological brain age prediction using machine learning on structural neuroimaging data: Multi- cohort validation against biomarkers of Alzheimer ’ s Disease and neurodegeneration stratified by sex. Elife. 2023;12:1–37.
Morris JC, Aisen PS, Bateman RJ, et al. Developing an international network for Alzheimer’s research: the dominantly inherited Alzheimer Network. Clin Investig (Lond). 2012;2:975–84.
Bateman RJ, Xiong C, Benzinger TLS, et al. Clinical and biomarker changes in dominantly inherited Alzheimer’s Disease. N Engl J Med. 2012;367:795–804.
Gonneaud J, Baria AT, Binette AP et al. (2021) Accelerated functional brain aging in pre-clinical familial Alzheimer’s Disease. Nat Commun 1–17.
Bashyam VM, Erus G, Doshi J et al. (2020) MRI signatures of brain age and Disease over the lifespan based on a deep brain network and 14 468 individuals worldwide. Brain 1–13.
Mann DMA, Pickering-Brown SM, Takeuchi A, et al. Amyloid angiopathy and variability in amyloid β deposition is determined by mutation position in presenilin-1-linked Alzheimer’s Disease. Am J Pathol. 2001;158:2165–75.
Ryan NS, Biessels GJ, Kim L, et al. Genetic determinants of white matter hyperintensities and amyloid angiopathy in familial Alzheimer’s Disease. Neurobiol Aging. 2015;36:3140–51.
Ryan NS, Nicholas JM, Weston PSJ, et al. Clinical phenotype and genetic associations in autosomal dominant familial Alzheimer’s Disease: a case series. Lancet Neurol. 2016;15:1326–35.
Chhatwal JP, Schultz SA, McDade EM, et al. Variant-dependent heterogeneity in amyloid β burden in autosomal dominant Alzheimer’s disease: cross-sectional and longitudinal analyses of an observational study. Lancet Neurol. 2022;21:140–52.
Cole JH, Ritchie SJ, Bastin ME, et al. Brain age predicts mortality. Mol Psychiatry. 2018;23:1385–92.
Goyal MS, Blazey TM, Su Y, Couture LE, Durbin TJ, Bateman RJ, Benzinger TLS, Morris JC, Raichle ME, Vlassenko AG. Persistent metabolic youth in the aging female brain. Proc Natl Acad Sci U S A. 2019;116:3251–5.
Beheshti I, Nugent S, Potvin O, Duchesne S. Disappearing metabolic youthfulness in the cognitively impaired female brain. Neurobiol Aging. 2021;101:224–9.
Sanford N, Ge R, Antoniades M, Modabbernia A, Haas SS, Whalley HC, Galea L, Popescu SG, Cole JH, Frangou S. Sex differences in predictors and regional patterns of brain age gap estimates. Hum Brain Mapp. 2022;43:4689–98.
Valdes Hernandez PA, Nodarse CL, Cole JH, Cruz-Almeida Y. Feasibility of brain age predictions from clinical T1-weighted MRIs. Brain Res Bull. 2023. https://doi.org/10.1016/j.brainresbull.2023.110811.
Steffener J, Habeck CG, Shea DO, Razlighi Q, Bherer L, Stern Y. Differences between chronological and brain age are related to education and self-reported physical activity. Neurobiol Aging. 2016;40:138–44.
Petersen KJ, Lu T, Wisch JK, Roman J, Metcalf N, Cooley SA, Babulal GM, Paul R, Sotiras A, Vaida F. Effects of clinical, comorbid, and social determinants of health on brain ageing in people with and without HIV : a retrospective case-control study. Lancet HIV. 2023;3018:1–10.
Löwe LC, Gaser C, Franke K. The effect of the APOE genotype on individual BrainAGE in normal aging, mild cognitive impairment, and Alzheimer’s Disease. PLoS ONE. 2016;11:1–25.
Wisch JK, Babulal GM, Petersen KJ, et al. A practitioner’s guide to geospatial analysis in a neuroimaging context. Alzheimer’s Dement Diagnosis Assess Dis Monit. 2023;15:1–5.
Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology. 1993;43:2412–4.
Su Y, D’Angelo GM, Vlassenko AG, et al. Quantitative analysis of PiB-PET with FreeSurfer ROIs. PLoS ONE. 2013. https://doi.org/10.1371/journal.pone.0073377.
Hansson O, Lehmann S, Otto M, Zetterberg H, Lewczuk P. Advantages and disadvantages of the use of the CSF amyloid β (Aβ) 42/40 ratio in the diagnosis of Alzheimer’s Disease. Alzheimer’s Res Ther. 2019;11:1–15.
Guo T, Korman D, La Joie R, Shaw LM, Trojanowski JQ, Jagust WJ, Landau SM. Normalization of CSF pTau measurement by Aβ40improves its performance as a biomarker of Alzheimer’s Disease. Alzheimer’s Res Ther. 2020;12:1–15.
Preische O, Schultz SA, Apel A, et al. Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s Disease. Nat Med. 2019;25:277–83.
Storandt M, Balota DA, Aschenbrenner AJ, Morris JC. Clinical and psychological characteristics of the initial cohort of the dominantly inherited alzheimer network (DIAN). Neuropsychology. 2014;28:19–29.
Wechsler D. (1987) WMS-R: Wechler Memory Scale-Revised: Manual.
Wechsler D. (1997) WAIS-III: Administration and Scoring Manual: Wechsler Adult Intelligence Scale.
Goodglass H, Kaplan E. (1983) Boston Diagnostic Aphasia Examination Booklet, III: Oral Expression: Animal Naming (Fluency in Controlled Association).
Armitage SG. An analysis of certain psychological tests use for the evaluation of Brain Injury. Psychol Monogr. 1946;60:1–48.
O’Bryant SE, Waring SC, Cullum CM, Hall J, Lacritz L, Massman PJ, Lupo PJ, Reisch JS, Doody R. Staging Dementia using clinical Dementia rating scale sum of boxes scores: a Texas Alzheimer’s research consortium study. Arch Neurol. 2008;65:1091–5.
McKay NS, Gordon BA, Hornbeck RC, et al. Positron emission tomography and magnetic resonance imaging methods and datasets within the dominantly inherited Alzheimer Network (DIAN). Nat Neurosci. 2023. https://doi.org/10.1038/s41593-023-01359-8.
Fischl B. FreeSurfer Neuroimage. 2012;62:774–81.
Gordon BA, Blazey TM, Su Y, et al. Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer’s Disease: a longitudinal study. Lancet Neurol. 2018;17:241–50.
Dincer A, Gordon BA, Hari-Raj A, et al. Comparing cortical signatures of atrophy between late-onset and autosomal dominant Alzheimer Disease. NeuroImage Clin. 2020. https://doi.org/10.1016/j.nicl.2020.102491.
Le TT, Kuplicki RT, McKinney BA, Yeh H-W, Thompson WK, Paulus MP. A nonlinear Simulation Framework supports adjusting for Age when analyzing BrainAGE. Front Aging Neurosci. 2018;10:1–11.
de Lange AMG, Cole JH. Commentary: correction procedures in brain-age prediction. NeuroImage Clin. 2020;26:24–6.
Butler ER, Chen A, Ramadan R et al. (2021) Pitfalls in brain age analyses. Hum Brain Mapp 1–10.
de Lange AMG, Anatürk M, Rokicki J, et al. Mind the gap: performance metric evaluation in brain-age prediction. Hum Brain Mapp. 2022;43:3113–29.
Fortin JP, Cullen N, Sheline YI, et al. Harmonization of cortical thickness measurements across scanners and sites. NeuroImage. 2018;167:104–20.
Koo TK, Li MY. A Guideline of selecting and reporting Intraclass correlation coefficients for Reliability Research. J Chiropr Med. 2016;15:155–63.
McDade EM, Wang G, Gordon BA, et al. Longitudinal cognitive and biomarker changes in dominantly inherited Alzheimer Disease. Neurology. 2018;91:e1295–306.
Boerwinkle AH, Gordon BA, Wisch JK, et al. Comparison of amyloid burden in individuals with Down syndrome versus autosomal dominant Alzheimer’s Disease: a cross-sectional study. Lancet Neurol. 2023;22:55–65.
Goldstein H, Healy MJR. The graphical presentation of a Collection of means. J R Stat Soc Ser A (Statistics Soc. 1995;158:175–7.
Payton ME, Greenstone MH, Schenker N. Overlapping confidence intervals or standard error intervals: what do they mean in terms of statistical significance? J Insect Sci. 2003. https://doi.org/10.1093/jis/3.1.34.
Ruppert D, Wand MP, Carroll RJ. (2003) Semiparametric Regression. Semiparametric Regres. https://doi.org/10.1201/9781420091984-c17.
Imai K, Keele L, Tingley D, Yamamoto T. (2010) Causal Mediation Analysis Using R. 129–154.
Morris JC, Weiner M, Xiong C, et al. Autosomal dominant and sporadic late onset Alzheimer’s Disease share a common in vivo pathophysiology. Brain. 2022;145:3594–607.
Stern Y, Arenaza-Urquijo EM, Bartrés-Faz D, et al. Whitepaper: defining and investigating cognitive reserve, brain reserve, and brain maintenance. Alzheimer’s Dement. 2020;16:1305–11.
Rother C, Uhlmann RE, Müller SA, et al. Experimental evidence for temporal uncoupling of brain Aβ deposition and neurodegenerative sequelae. Nat Commun. 2022. https://doi.org/10.1038/s41467-022-34538-5.
Barthélemy NR, Li Y, Joseph-Mathurin N, et al. A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer’s Disease. Nat Med. 2020;26:398–407.
Mattsson-Carlgren N, Andersson E, Janelidze S, et al. Aβ deposition is associated with increases in soluble and phosphorylated tau that precede a positive tau PET in Alzheimer’s Disease. Sci Adv. 2020. https://doi.org/10.1126/sciadv.aaz2387.
Bacas E, Kahhalé I, Raamana PR, Pablo JB, Anand AS, Hanson JL. (2023) Probing Multiple Algorithms to Calculate Brain Age: Examining Reliability, Relations with Demographics, and Predictive Power. Hum Brain Mappin 2022.06.17.496576.
Hanson JL, Adkins D. (2023) Preprint: examining the reliability of Brain Age algorithms under varying degrees of subject motion. Res Sq 1–21.
Dörfel RP, Arenas-Gomez JM, Fisher PM, Ganz M, Knudsen GM, Svensson J, Plaven-Sigray P. Preprint: prediction of brain age using structural magnetic resonance imaging: a comparison of accuracy and test-retest reliability of publicly available software packages. bioRxiv. 2023;56:1–14.
Sundermann EE, Biegon A, Rubin LH, Lipton RB, Mowrey W, Landau S, Maki PM. Better verbal memory in women than men in MCI despite similar levels of hippocampal atrophy. Neurology. 2016;86:1368–76.
Sundermann EE, Maki PM, Rubin LH, Lipton RB, Landau S, Biegon A. Female advantage in verbal memory. Neurology. 2016;87:1916–24.
Digma LA, Madsen JR, Rissman RA, Jacobs DM, Brewer JB, Banks SJ. Women can bear a bigger burden: ante- and post-mortem evidence for reserve in the face of tau. Brain Commun. 2020. https://doi.org/10.1093/braincomms/fcaa025.
Iulita MF, Bejanin A, Vilaplana E, et al. Association of biological sex with clinical outcomes and biomarkers of Alzheimer’s Disease in adults with Down syndrome. Brain Commun. 2023;5:1–16.
Vila-Castelar C, Guzmán-Vélez E, Pardilla-Delgado E, et al. Examining sex differences in Markers of Cognition and Neurodegeneration in autosomal Dominant Alzheimer’s Disease: preliminary findings from the Colombian Alzheimer’s Prevention Initiative Biomarker Study. J Alzheimer’s Dis. 2020;77:1743–53.
Wagemann O, McKay NS, Li Y et al. (2023) Investigation of sex differences in mutation carriers of the dominantly inherited Alzheimer Network. Alzheimer’s Dement 1–16.
McCarthy MM, Arnold AP. Reframing sexual differentiation of the brain. Nat Neurosci. 2011;14:677–83.
Elliott ML, Belsky DW, Knodt AR, Ireland D, Melzer TR, Poulton R, Ramrakha S, Caspi A, Moffitt TE, Hariri AR. Brain-age in midlife is associated with accelerated biological aging and cognitive decline in a longitudinal birth cohort. Mol Psychiatry. 2021;26:3829–38.
Vidal-Piñeiro D, Phd D, Wang Y et al. (2021) Individual variations in brain age relate to early life factors more than to longitudinal brain change. Elife 2021.02.08.428915.
Richard G, Kolskår K, Sanders AM, et al. Assessing distinct patterns of cognitive aging using tissue-specific brain age prediction based on diffusion tensor imaging and brain morphometry. PeerJ. 2018;2018:1–27.
Cole JH. Multimodality neuroimaging brain-age in UK biobank: relationship to biomedical, lifestyle, and cognitive factors. Neurobiol Aging. 2020;92:34–42.
Petersen KJ, Metcalf NV, Cooley S, Tomov D, Vaida F, Paul R, Ances BM. Accelerated brain aging and cerebral blood Flow reduction in persons with human immunodeficiency virus. Clin Infect Dis. 2021;73:1813–21.
Cole JH, Annus T, Wilson LR, et al. Brain-predicted age in Down syndrome is associated with beta amyloid deposition and cognitive decline. Neurobiol Aging. 2017;56:41–9.